Latest filing published 28 Apr 2008 for EPIRUS Biopharmaceuticals, Inc., €3,636.
Insider track record
No signal scores available.
Lynn G. Baird: trading record in brief
Lynn G. Baird discloses dealings in EPIRUS Biopharmaceuticals, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 24 April 2006 to 24 April 2008.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 28 April 2008, reports a share grant of €3,636 in EPIRUS Biopharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Lynn G. Baird
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,588 shares@ US$3.58Common StockSEC:0001181431-08-026842:0
- 20,000 shares0Common Stock, par value $0.001SEC:0001179110-06-009123:0
2 of 2 declarations
